Business Context and Reporting Period
This Form 6-K filing by Sanofi-Synthelabo, dated January 17, 2003, serves as a notification regarding the upcoming publication of the company's 2002 annual sales results. The filing announces a conference call scheduled for January 22, 2003, to discuss these results with financial analysts, institutional investors, and journalists.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is an announcement of an event rather than a financial report containing numerical data.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in this document, as the actual 2002 financial results are yet to be presented during the announced conference call.
Guidance, Outlook, and Management Commentary
Management has scheduled a conference call for Wednesday, January 22, 2003, at 3:00 p.m. Paris time to discuss the 2002 sales publication. The call will be conducted in English. No specific guidance, outlook, or risk factors are detailed in this text.
- Live Webcast: Available at www.sanofi-synthelabo.com.
- Recorded Version: Available via phone or webcast archive through January 31, 2003.
- Conference Call Access: Dial-in numbers and codes are provided for France, the United Kingdom, and the USA.
Investor Verification Checklist
- Verify the actual 2002 sales figures and financial performance during the January 22, 2003, conference call.
- Confirm the availability of the recorded conference call if unable to attend the live session.
- Review the full 2002 annual report (Form 20-F) once published for detailed financial statements.
- Check for any subsequent press releases regarding the 2002 results following the conference call.